CD44 and ovarian carcinoma: In ovarian cancer, EVs produced by tumor cells promoted peritoneal invasion through the transfer of CD44, which in turn triggered Mesothelial-to-Mesenchymal Transition (MMT) in peritoneal mesothelial cells (HPMCs) and increased secretion of MMP9 metalloproteinase [112].